Published in the Journal of Conditions Nobody in Power Will Acknowledge Peer-reviewed by people who will never be promoted
Sudden Onset Executive Encephalopathy (SOEE) is a progressive neurocorporate disorder affecting an estimated 89% of C-suite professionals, typically manifesting within 6–18 months of promotion to senior leadership. The condition is characterized by a dramatic and measurable decline in the ability to process information originating from subordinate organizational layers, a paradoxical hypersensitivity to the opinions of other executives, and an advanced capacity for generating elaborate justifications for decisions that were already made before any input was solicited. First identified informally in break rooms and Slack DMs as far back as the 1970s under colloquial names such as "executive brain rot," "corner office syndrome," and "oh for fuck's sake, not again," SOEE was formally classified in 2024 after researchers determined that the pattern was far too consistent, too widespread, and too devastatingly predictable to be mere coincidence.
The precise mechanism by which SOEE develops remains under investigation, though current models point to a complex interplay of environmental, social, and compensation-related factors.
The leading theory suggests that upon assuming a C-suite role, patients rapidly develop what researchers have termed a Blood-Office-Barrier (BOB)—a semi-permeable cognitive membrane that selectively filters incoming information based on its source rather than its content. Data, insights, and warnings originating from employees below the VP level are effectively blocked at this barrier, while identical information repackaged by McKinsey at 400 times the cost passes through freely and is hailed as "groundbreaking" and "exactly the kind of strategic thinking we need right now." The BOB appears to calcify over time. In early stages, patients may still occasionally register employee input, though they will typically attribute any useful ideas to their own "gut instinct" within 48 hours. In advanced stages, the barrier becomes virtually impenetrable, and employees report the unmistakable sensation that they are speaking into an ornamental void.
Emerging research from the University of Nobody Asked has identified a unique microbiome present in executive suites, private elevators, and reserved parking spaces. This microbiome, dominated by the bacterium Sycophantus validatus, appears to colonize the prefrontal cortex and gradually replace evidence-based reasoning with a proprietary cognitive framework best described as "vibes from Davos."
A longitudinal study tracking 3,000 professionals over 15 years found a near-perfect inverse correlation between total compensation and the ability to hear the phrase "that's not going to work" from someone who actually does the work. For every $100,000 increase in annual compensation beyond $500,000, subjects demonstrated a 12% decrease in receptivity to frontline feedback and a corresponding 15% increase in the use of the phrase "I hear you, but—."
SOEE presents with a remarkably consistent constellation of symptoms, organized here by clinical category.
Perhaps the hallmark feature of SOEE is the near-total replacement of independent strategic thinking with what clinicians have termed Executive Herd Compliance (EHC). Patients display an irresistible compulsion to adopt whatever strategy, policy, or buzzword is currently circulating among other C-suite leaders in their industry, regardless of whether the strategy makes sense, has any supporting evidence, or has already failed spectacularly at three competitor firms.
- Making major strategic pivots within 72 hours of attending an industry conference, invariably prefaced by "I had some really interesting conversations in Aspen/Davos/Sun Valley."
- An inability to articulate why a decision is being made beyond "this is where the industry is heading," which, upon further examination, means "two other CEOs I had dinner with are doing this."
- Treating the opinions of fellow executives with the reverence normally reserved for peer-reviewed meta-analyses, while treating actual peer-reviewed meta-analyses prepared by their own research teams with the indifference normally reserved for Terms of Service agreements.
- Subscribing to whatever management philosophy was most recently featured in Harvard Business Review, implementing it with missionary zeal for four to seven months, then quietly abandoning it and pretending it never happened.
Case Study: In 2023, a technology CEO with advanced HMRD laid off 14% of the workforce after reading that three competing CEOs had done the same. When asked by the board for the strategic rationale, the patient reportedly said, "We need to run lean," despite the company being profitable, fully staffed to current project demands, and in the middle of an aggressive hiring campaign that had concluded just eleven weeks earlier. The patient later hired back 60% of the terminated employees as contractors at higher cost. When confronted with this outcome, the patient described it as "an optimization."
SIRS manifests as a systematic inability to process, retain, or act upon information provided by employees, particularly when that information contradicts a decision the patient has already emotionally committed to.
- Scheduling "listening sessions" and "town halls" that function as one-directional information broadcasts with a Q&A segment carefully managed to avoid any question of substance.
- Responding to detailed, data-rich employee reports with "Thanks for this—let's take it offline," where "offline" is a clinical euphemism for "into the void."
- Commissioning an internal task force to study a problem, receiving the task force's recommendations, and then hiring an external consultant to study the same problem because "we need an outside perspective," which invariably means "we need someone who will tell us what we want to hear."
- The pathological use of the phrase "That's great feedback" as a terminal conversational marker, after which no action of any kind is taken.
A key diagnostic distinction must be made between SIRS and simple rudeness. In SIRS, patients genuinely believe they are being receptive to input. Brain imaging studies conducted at the Institute for Things That Should Be Obvious reveal that when SOEE patients say "my door is always open," the neural regions associated with sincerity do, in fact, activate—even as the neural regions associated with follow-through remain completely dark. This dissociation is one of the most fascinating and infuriating features of the disease.
Closely related to SIRS, GMD is characterized by a compulsive need to minimize, reframe, or structurally disappear employee complaints.
- The Acknowledgment Stage: "We hear your concerns." (Duration: one email.)
- The Reframing Stage: "We understand the frustration, but let's think about this as an opportunity." (The opportunity is never specified.)
- The Bureaucratic Diffusion Stage: "We've asked HR to look into this and develop a framework for ongoing dialogue." (The framework is a survey. The survey results are never shared.)
- The Structural Amnesia Stage: "I think we've already addressed this." (They have not.)
- The Gaslighting Stage: "I'm not sure that's an accurate characterization of the situation." (It is.)
Patients with advanced GMD often develop a secondary condition known as Selective Empathy Activation, in which they demonstrate profound emotional intelligence when discussing customer experience, brand perception, or their own work-life balance, but become strikingly obtuse when an employee raises concerns about workload, compensation, or the fact that the company's parental leave policy was apparently written in 1987 by someone who had never met a child.
One of the most clinically dramatic manifestations of SOEE is Proximity Fixation Syndrome, an irrational and deeply held belief that physical presence in a designated corporate space is essential to productivity, collaboration, and "culture"— despite overwhelming evidence to the contrary, including the patient's own company's record-breaking performance during years of remote work.
- Issuing return-to-office mandates while being unable to cite a single metric that deteriorated during remote work.
- Using the word "collaboration" an average of 47 times per all-hands meeting without once defining what it means or how sitting in traffic for 90 minutes facilitates it.
- Claiming that "the best ideas happen in hallway conversations" while maintaining a personal schedule so packed with back-to-back meetings that they haven't had a hallway conversation since 2019.
- Investing $40 million in a redesigned open-plan office optimized for "spontaneous interaction" that employees immediately fill with noise-canceling headphones and "Do Not Disturb" signs so they can do their actual work.
- Describing the return-to-office policy as "not about trust" in a tone that makes it unambiguously clear it is entirely about trust.
- Privately working from home, from vacation properties, or from "off-site strategy sessions" held at resorts while enforcing mandatory in-office attendance for everyone else.
- When confronted with the hypocrisy, saying, "My role is different," with zero elaboration.
Case Study: A Fortune 500 CHRO with advanced PFS mandated four days per week in-office for all employees, citing "the energy of being together." A subsequent internal study found that on an average in-office day, employees spent 71% of their time on Zoom calls with colleagues in other offices, 14% of their time walking to and from the one good coffee machine, and the remaining 15% quietly questioning their life choices. The CHRO described the transition as "a huge success" based on badge-swipe data showing increased building occupancy, which is technically a measurement of something but not of anything useful.
Perhaps the most corrosive symptom of SOEE is Strategic Opacity Syndrome, the pathological inability to communicate honestly with employees about the reasoning behind decisions.
- Saying "I wish I could tell you more, but I can't right now" when in fact they could but have chosen not to because the honest explanation ("The board panicked and we're copying what our competitors did") is embarrassing.
- Using the phrase "transparent" or "transparency" with increasing frequency in direct proportion to how non-transparent the organization is actually being—a phenomenon researchers have dubbed the Transparency Paradox or, less formally, the "Methinks the Lady Doth Protest Too Much" Index.
- The Bullshit Escalation Cycle: Clinicians have documented a predictable feedback loop in SOS. As employees become more skeptical due to repeated exposure to corporate non-answers, patients respond not by increasing actual transparency but by increasing the performance of transparency—more town halls, more "candid" memos, more "fireside chats" that are neither fireside nor chats. This escalation continues until the organization reaches a state researchers call Peak Bullshit, at which point employees stop asking questions entirely and simply monitor LinkedIn and Blind for actual information about their own company.
SOEE rarely occurs in isolation. Common comorbidities include:
- Metric Myopia: The inability to value any outcome that cannot be expressed as a number on a quarterly dashboard, leading to the systematic undervaluation of employee satisfaction, institutional knowledge, and anything that takes longer than 90 days to show results.
- Initiative Fatigue Induction: A compulsive need to launch new strategic initiatives at a rate that makes it impossible for any single initiative to be properly implemented, creating an organizational environment of perpetual semi-transformation that employees experience as exhausting chaos but that patients describe on earnings calls as "agility."
- Consultancy Dependency Disorder: A chronic reliance on external consulting firms to provide validation for internal decisions, at fees that would comfortably fund the salaries of the employees whose recommendations were ignored in the first place.
- Empathy Performance Disorder: The ability to convincingly simulate empathy in public forums—using phrases like "our people are our greatest asset" and "I lose sleep over these decisions"—while making decisions that demonstrate an advanced understanding of spreadsheets and a novice understanding of human beings.
- Founder's Syndrome (Late-Stage): In cases where the patient founded the company, a delusional belief that the cultural norms, work patterns, and compensation structures that were appropriate for a 12-person startup remain appropriate for a 12,000-person publicly traded corporation.
The DSM-C (Diagnostic and Statistical Manual of Corporate Disorders) requires the presence of at least four of the following seven criteria for a formal SOEE diagnosis:
- Patient has disregarded a substantive internal report in favor of an external report containing identical conclusions at 50x the cost within the past 12 months.
- Patient has used the phrase "culture" to justify a policy that primarily benefits management's desire for control.
- Patient has announced a "transformation" or "reorganization" that, upon completion, results in the same structure with different nomenclature.
- Patient demonstrates the ability to make eye contact and say "people are our top priority" within 30 days of a significant layoff.
- Patient has cited "industry trends" as justification for a decision while being unable to produce any first-party data supporting the decision.
- Patient's calendar contains more time blocked for "strategic thinking" and "leadership offsites" than for direct interaction with non-executive employees by a ratio of at least 5:1.
- Patient has used the word "transparent" in an all-hands meeting in which nothing of substance was disclosed.
Treatment for SOEE has proven exceptionally challenging, primarily because the condition is self-reinforcing: patients are surrounded by other patients who validate their symptoms, and the organizational structures they inhabit are specifically designed to insulate them from the feedback that might prompt recovery.
- 360-Degree Feedback Programs: Theoretically promising but practically useless, as patients either (a) receive sanitized feedback because employees have correctly concluded that honesty is career suicide, or (b) receive honest feedback and dismiss it as "not representative" or "from people who don't see the full picture."
- Compensation Recalibration: Experimental treatment in which executive compensation is partially tied to employee satisfaction and retention metrics. Showed dramatic efficacy in early trials but was universally rejected by patients, who described it as "not aligned with shareholder value" and "a fundamental misunderstanding of how executive performance should be measured."
- Direct Truth Exposure Therapy (DTET): A structured program in which patients are exposed to incrementally increasing doses of honest employee feedback in a controlled setting. Discontinued after multiple patients experienced Cognitive Anaphylaxis—a severe defensive reaction characterized by crossed arms, audible sighing, and the immediate invocation of "context you're not aware of."
The only intervention with demonstrated long-term efficacy is retirement, which removes the patient from the corporate environment and eliminates the primary vector of transmission. Unfortunately, many retired patients subsequently join boards of directors, where they serve as carriers, infecting the next generation of executives.
SOEE affects executives across all industries, geographies, and educational backgrounds, though certain risk factors have been identified:
- MBA from a top-10 program (OR: 3.7)
- Previous career in management consulting (OR: 5.2)
- Regular attendance at the World Economic Forum (OR: 8.1)
- Use of the phrase "servant leadership" in professional biography while exhibiting zero servant leadership behaviors (OR: 11.4)
- Possession of a personal branding strategy on LinkedIn (OR: 6.8)
Notably, the condition shows no gender disparity, confirming that SOEE is an equal-opportunity affliction that transcends all demographic categories in its capacity to make life worse for everyone who is not an executive.
It would be incomplete to discuss SOEE without acknowledging the structural factors that enable its proliferation. Corporate governance systems, as currently designed, create an almost perfect incubation environment for the disease:
- Board composition typically consists of other current or former C-suite executives, ensuring that the patient's reference group is composed entirely of individuals with the same condition.
- Executive compensation structures reward short-term financial metrics, creating a powerful incentive to ignore the long-term employee and organizational health indicators that might otherwise trigger symptom awareness.
- The leadership development pipeline selects for traits—supreme confidence, comfort with ambiguity (which in practice often means comfort with bullshitting), and "executive presence" (which in practice often means height and a firm handshake)— that are strongly correlated with SOEE susceptibility.
Until these structural determinants are addressed, SOEE will continue to be endemic in the corporate population, and employees will continue to gather in break rooms, group chats, and anonymous forums to conduct their own informal epidemiological surveillance.
Sudden Onset Executive Encephalopathy remains one of the most pervasive and least acknowledged disorders in organizational life. Its symptoms are visible to virtually everyone except those who have it. Its costs—measured in employee turnover, lost institutional knowledge, squandered potential, and the slow erosion of trust that transforms workplaces from communities of shared purpose into theaters of performative corporate jargon—are staggering and almost entirely unquantified, because the people who would need to authorize the study are the same people who have the condition.
Until a cure is found, frontline employees are advised to maintain a supportive peer network, practice emotional detachment during all-hands meetings, and keep their LinkedIn profiles updated.
The authors report no conflicts of interest, primarily because they have been laid off and no longer have interests that could conflict with anything.
Correspondence should be directed to the authors' personal email addresses, as their corporate accounts have been deactivated effective immediately as part of an exciting organizational optimization.
Ten Pharmacological Interventions for Sudden Onset Executive Encephalopathy (SOEE)
-
Subordinol™ (listenafil hydrochloride) A selective serotonin-reuptake-doesn't-matter-because-they-won't-take-it inhibitor that temporarily lowers the Blood-Office-Barrier, allowing data from non-VP sources to reach the prefrontal cortex. In clinical trials, patients on Subordinol were able to sit through an entire employee presentation without checking their phone or mentally composing a LinkedIn post. Side effects include fleeting moments of self-awareness, which resolve quickly upon returning to the corner office.
-
Herdazine™ (conformatib) An anti-herd monoclonal antibody designed to neutralize Executive Herd Compliance by blocking the Davos receptor. Patients taking Herdazine reported a 34% reduction in the urge to make major strategic pivots after dinner with other CEOs. Discontinued in Phase III trials after subjects began forming independent opinions and experienced severe board-level rejection.
-
McKinsaway™ (consultectomab) A targeted therapy for Consultancy Dependency Disorder that works by mimicking the neurochemical signature of a $4.2 million slide deck, thereby satisfying the patient's craving for external validation without requiring actual expenditure. Administered as a monthly injection of saline accompanied by a invoice for $350,000, which appears to be the pharmacologically active component.
-
Transparex™ (candorfenac extended-release) Indicated for Strategic Opacity Syndrome (SOS), Transparex acts on the Broca's area to disrupt the generation of phrases like "I wish I could tell you more" and "let's take that offline." In early trials, one patient inadvertently told an all-hands meeting the actual reason for a reorganization. The episode was classified as a severe adverse event by the compensation committee.
-
Proximitol CR™ (returntonofloxacin) A controlled-release formulation targeting Proximity Fixation Syndrome. Proximitol works by decoupling the patient's amygdala response from the sight of empty office chairs, reducing the neurological panic that drives return-to-office mandates. Contraindicated in patients who have recently invested $40 million in an open-plan redesign, as the resulting cognitive dissonance may cause seizures.
-
Empathex™ (simulceritide) Not to be confused with drugs that produce actual empathy, Empathex closes the well-documented gap between performed empathy and functional empathy by forcing the two neural systems to communicate with each other for the first time. The most common side effect is a sudden, paralyzing awareness that "our people are our greatest asset" and "we're eliminating 14% of our greatest asset" are contradictory statements. Most patients discontinue treatment voluntarily within 48 hours, citing "philosophical differences with the medication."
-
Feedbacitol™ (three-sixtamine) A desensitization agent used in preparation for Direct Truth Exposure Therapy (DTET), Feedbacitol dampens the Cognitive Anaphylaxis response by suppressing the arm-crossing reflex and reducing audible sighing by up to 60%. Does not, however, prevent the patient from invoking "context you're not aware of." Researchers are seeking a higher dose formulation for that.
-
Sycophex-B™ (microbiostatinib) A narrow-spectrum antibiotic targeting Sycophantus validatus, the dominant organism in the Corner Office Microbiome. While effective at reducing bacterial load in laboratory settings, real-world efficacy has been limited, as the organism rapidly recolonizes from environmental reservoirs including executive assistants who have learned that survival depends on it, sycophantic middle managers, and the collected works of Simon Sinek.
-
Initiavex™ (pivotazolam) A mood stabilizer for Initiative Fatigue Induction that regulates the compulsive need to launch new transformation programs. Patients on Initiavex demonstrated the ability to allow a single strategic initiative to run for up to nine months before replacing it—nearly triple the untreated duration. Prescribing information warns that abrupt discontinuation may result in the patient announcing three simultaneous reorganizations in a single earnings call.
-
Metriquelm™ (dashboardiprazole) Indicated for Metric Myopia, Metriquelm selectively inhibits the brain's quarterly-dashboard reward pathway, allowing the patient to perceive value in outcomes that cannot be expressed as a KPI. In clinical trials, one subject on the highest dose spontaneously asked, "But are people okay?"—the first recorded instance of this question from a sitting C-suite executive. The moment was brief. The subject's next sentence was "And can we quantify that?" Researchers remain cautiously pessimistic.
All medications require prior authorization from someone who reports to the patient, which is—yes—exactly the problem. None are covered by the executive health plan, which ironically covers everything else, including concierge psychiatry, boutique wellness retreats, and the spiritual costs of servant leadership.